AHR and melanoma: Thus, we tested ABT-263, SB505124, Afatinib, and CHIR−99021_1241 on the melanoma line SKMel28 in the presence, or not, of the AhR transcription factor (CRISPR-Cas9 silencing) (Figure 5A).